Recognized for its biotech-first focus, innovation in clinical trial delivery, and best-in-class client experience, Novotech sets the global standard in contract research for biotechs and small- ...

Phase 1b studies for ABI-1179 and ABI-5366 running concurrently ... Assembly Bio’s ability to maintain financial resources necessary to continue its research activities, clinical studies and other ...

The initial implementation phase of myUABResearch, the university’s new electronic research administration system, is on ...

After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

Fintel reports that on July 1, 2025, Wolfe Research initiated coverage of Verona Pharma plc - Depositary Receipt () (NasdaqGM ...

Thermo Fisher Scientific’s Accelerator™ Drug Development solutions, which integrate services for contract development and manufacturing organizations (CDMOs) and contract research organizations (CROs) ...

In recognition of its innovation, client-focused delivery, and global impact, Novotech has been awarded the 2025 Global Biotechnology Contract Research Organization (CRO) Company of the Year by Frost ...

The global Phase III PROMINENT trial has begun dosing patients to evaluate felzartamab in treating primary membranous nephropathy, a serious autoimmune kidney disorder with no FDA-approved therapies.

The next frontier in clinical development is modelling feasibility and continuous scenario-planning, even amid changing ...

New research reveals that combining lurbinectedin with atezolizumab significantly improves survival rates for patients with ...

Read highlights things to do, places to go and people to know in the Greater Lowell area. Have news to share? Send it to news ...